Brief: Wilex H1 sales revenue and income down at EUR 1.1 mln
July 13 (Reuters) - WILEX AG WL6G.DE :
* H1 SALES REVENUE AND INCOME TOTALING EUR 1.1 MILLION, A
DECREASE OF 42% COMPARED TO PREVIOUS YEAR (EUR 1.9 MILLION
* NET LOSS FOR FIRST HALF OF YEAR ROSE TO EUR 4.1 MILLION
FROM EUR 2.4 MILLION FOR SAME PERIOD IN 2016
* CONFIRMS ITS GUIDANCE FOR CURRENT FISCAL YEAR PROVIDED AT
END OF MARCH 2017
Source text for Eikon: ID:nEQK4CGba
Further company coverage: WL6G.DE
(Gdynia Newsroom)
((gdynia.newsroom@thomsonreuters.com; +48 58 722 0920;))
Recent news on Heidelberg Pharma AG
See all newsBrief: Heidelberg Pharma And Huadong Medicine Receive Nmpa Approval For Hdp-101 Trial In China
Germany's Heidelberg Pharma H1 sales revenue surges, driven by milestone payments
Brief: Heidelberg Pharma Says Co. And Healthcare Royalty Announce Amendment To Existing Royalty Agreement
Brief: Redhill Biopharma Secures Allowance Of Key Chinese Patent Application For Proprietary COVID-19 Treatment, RHB-107
Brief: Heidelberg Pharma Amends Royalty Financing With Healthcare Royalty